# CLEARSIGHT THERAPEUTICS, INC.: Novel preservative-free eyedrop with  antimicrobial and anti-inflammatory properties for treating Acute Infectious Conjunctivitis and Epidemic KeratoConjuntivitis (EKC)

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | CLEARSIGHT THERAPEUTICS, INC. |
| Location | DALLAS, TX |
| Project | Novel preservative-free eyedrop with  antimicrobial and anti-inflammatory properties for treating Acute Infectious Conjunctivitis and Epidemic KeratoConjuntivitis (EKC) |
| Project number | 1R43EY039140-01 |
| Mechanism | R43 |
| Institute | National Eye Institute |
| Award | $306,852 |
| Awarded | 2026-09-16 |
| Project period | 2026-09-15 to 2027-08-31 |
| UEI | Z3JEGN7JHR18 |

## Why this score
- Award of $306,852.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11406896). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.